Oriheal Palapan-Vet Pantoprazole 40mg Injection for Dogs & Cats | Gastric Ulcer, GERD, Erosive Oesophagitis & NSAID-Induced Gastric Damage | Veterinary Prescription

Prescription Required — For veterinary use only. Administer strictly under the supervision of a licensed veterinarian. Injectable medicine — for intravenous (IV) or intramuscular (IM) administration by a qualified veterinary professional only.

Oriheal Palapan-Vet Pantoprazole 40mg Injection for Dogs & Cats

Oriheal Palapan-Vet is a veterinary prescription injectable formulation of Pantoprazole Sodium (40mg per vial), a proton pump inhibitor (PPI), manufactured by Oriheal Lifesciences. The parenteral (IV/IM) route provides more rapid and reliable gastric acid suppression than oral PPI formulations, making it the preferred option when oral administration is not feasible (vomiting, post-surgical NPO, severe gastric disease) or when rapid acid control is required. Indicated for the management of gastric ulcers, GERD, erosive oesophagitis, NSAID- and corticosteroid-induced gastric mucosal damage, and gastritis in dogs and cats.

Composition (per vial)

• Pantoprazole Sodium — 40mg (equivalent to Pantoprazole 40mg) — lyophilised powder or solution for reconstitution/injection (confirm presentation from label)
• Vehicle/excipients — confirm from product label

Mechanism of Action

• Pantoprazole irreversibly inhibits the H+/K+-ATPase (gastric proton pump) in parietal cells — produces potent, sustained suppression of gastric acid secretion regardless of stimulus
• Parenteral administration bypasses first-pass hepatic metabolism — achieves faster and more predictable plasma levels than oral dosing; particularly effective when oral route is unavailable or unreliable
• Elevated intragastric pH supports healing of ulcers, erosive oesophagitis, and NSAID-induced mucosal lesions

Therapeutic Class

• Veterinary proton pump inhibitor (PPI) / gastric acid suppressant — parenteral (IV/IM) prescription injection for dogs and cats

Key Benefits

• Rapid onset of gastric acid suppression via parenteral route — preferred when oral administration is not feasible
• Effective for NSAID- and corticosteroid-induced gastric mucosal damage — treatment and prevention in at-risk patients
• Supports healing of gastric and duodenal ulcers and erosive oesophagitis
• Controls vomiting associated with gastric mucosal inflammation and gastric acid hypersecretion
• GERD and chronic acidity management where parenteral PPI therapy is clinically indicated

Indications

• Gastric and duodenal ulcers in dogs and cats
• Erosive oesophagitis and gastro-oesophageal reflux disease (GERD)
• NSAID-induced and corticosteroid-induced gastric mucosal damage
• Gastritis and chronic gastric acidity
• Vomiting associated with gastric mucosal inflammation
• Parenteral PPI therapy when oral administration is contraindicated or not feasible

Directions for Use

• Administer by intravenous (IV) or intramuscular (IM) injection as directed by a licensed veterinarian
• Reconstitute and prepare strictly per label instructions and veterinary protocol
• Dosage determined by species, body weight, and clinical condition — refer to veterinary prescription
• Do not administer without veterinary supervision; IV administration should be performed by a qualified veterinary professional

Safety Information

• Prescription medicine — for veterinary use only; injectable administration by a licensed veterinary professional only
• Long-term PPI therapy may affect absorption of Vitamin B12, magnesium, and calcium — monitor on extended parenteral or oral PPI therapy
• May alter absorption of drugs requiring gastric acid (e.g. ketoconazole, itraconazole) — consider timing and interaction when co-administering
• Keep out of reach of children; store as directed on label (lyophilised vials typically require refrigeration); use immediately after reconstitution